Article Per Year (5 Year)
p-Index From 2021 - 2026
0.817
P-Index
This Author published in this journals
All Journal IDJP (Indonesian Journal of Pharmaceutics) Jurnal Ilmiah Kesehatan Masyarakat
Insan Sunan Kurniawansyah, Insan Sunan
Unknown Affiliation
Dentistry Health Professions Medicine & Pharmacology Nursing Public Health Veterinary

Published : 4 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 4 Documents
Search

 1 
Pengukuran Dan Sosialisasi Terkait Pengetahuan Masyarakat Dalam Penanganan Infeksi Awal Influenza Melalui Media Sosial Windhu Wardhana, Yoga; Ghozali, Dolih; Kautsar, Angga P.; Kurniawansyah, Insan Sunan
SEHATMAS: Jurnal Ilmiah Kesehatan Masyarakat Vol. 1 No. 4 (2022): Oktober 2022
Publisher : Yayasan Literasi Sains Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55123/sehatmas.v1i4.763

Abstract

Recently, the world has been hit by a pandemic caused by a virus of the type of influenza that spreads very quickly, called COVID-19. It is named that cause of the disease from this type of influenza virus is relatively new and has not been widely known and began to spread at the end of 2019. Influenza itself is an acute respiratory tract infection (ARTI) caused by an influenza virus from the Orthomyxoviridae family, which can cause mild to severe symptoms. To avoid the occurrence of more severe or recurrent infections requires prevention and proper handling of the influenza disease. But in fact, there are still many Indonesian people who underestimate this and think that the flu is an ordinary disease because this disease actually can heal on its own. To reduce the spread or break the chain of transmission of the influenza virus, the community needs to adequate awareness and knowledge given. Through virtual KKN-PPMD activities, we want to learn the extent of public knowledge about how to prevent and treat early influenza infection. In this activity, an assessment will be given at the beginning and end of providing education related to knowledge for the prevention and handling of early influenza infections. The provision of virtual education was distributed through social media (Youtube, Whatsapp, Instagram, Facebook). The activity results from the category of random respondents in which the majority were women by 73%, with ages ranging from 15-35 years and status as students, it was found that a significant increase in knowledge showed that from each groups as like age group, education level, and type of work, namely 3,495 (sig. 0.062), 5.017 (sig. 0.025), and 1.140 (sig. 0.286).
 A Comparative Study on The Therapeutic Effect of pH, Temperature Triggered, and Ion Activated In Situ Gelling System For Ocular Delivery Kurniawansyah, Insan Sunan; Farisa Desy Arya, Insi; Budiman, Arif; Zubaidah, and
Indonesian Journal of Pharmaceutics Vol 6, Issue 2, May - August 2024
Publisher : Universitas Padjadjaran (Unpad)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24198/idjp.v6i2.52695

Abstract

One of the most popular pharmaceutical preparations for the eyes today is in situ gel. The in situ gel system is a system that is liquid at room temperature but will form a gel when it comes into contact with the body or undergoes a change in pH. The form of the drug delivery system is in-situ is a type of mucoadhesive drug delivery system. Gel formation depends on several factors such as temperature modulation, pH changes, the presence of ions, ultra-violet irradiation, electrical sensitivity, and the enzyme by which the active substance is released. The purpose of this study is to compare the therapeutic efficacy of in situ gel medicines on pH, temperature triggered, and ion activated gelling systems. A drug in situ gel is a drug delivery device that transforms into a gel after being applied to the body. The findings revealed that the pH, temperature triggered, and ion activated gelling system factors had a substantial influence on the extended release medicines that affect the therapeutic effect of in situ gel medications. This comparative investigation demonstrates that the pH, temperature triggered, and ion activated gelling system factors have significant implications on the therapeutic benefits of in situ gelled medicines. A deeper knowledge of the relationships between these variables and in situ gel drug delivery methods can lead to the development of more effective and dependable medication compositions. These findings could aid in the development of improved gel in situ drug delivery systems to improve therapeutic benefits in the treatment of a variety of medical disorders.  Keywords: in situ gel, pH triggered, temperature triggered, ion activated, therapeutic effect.
 A Concise ReviewThe Ph Triggered Concept In Situ Ophthalmic Gel Of Sodium Cromoglycate, Diclofenac Sodium and Aceclofenac Kurniawansyah, Insan Sunan; Farisa Desy Arya, Insi; Sopyan, Iyan
Indonesian Journal of Pharmaceutics Vol 6, Issue 3, Sept - Dec 2024
Publisher : Universitas Padjadjaran (Unpad)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24198/idjp.v6i3.52748

Abstract

The ophthalmic solutions have a major problem that is the poor bioavailability, such as the attainment of optimal drug concentration at the site of action, which is compromised mainly due to precorneal loss resulting in only small fraction of the drug being ocularly absorbed. This is overcome by developing an in situ ophthalmic gel which increases the retention time of the drug. The present review describes the formulation and evaluation of in situ gel-forming ophthalmic drug delivery system of an anti allergy drug sodium cromoglycate, an anti-inflammatory drug diclofenac sodium and aceclofenac based on the pH triggered concept in situ gelation. All the formulations varies in concentration and the content used. Based on the results obtained, Sodium cromoglycate which has been formulated with gelrite and HPMC E15LV has the highest ocular residence time compared to the other two formulations.Keywords: Ophthalmic in situ gel,sodium cromoglycate, diclofenac sodium,                      aceclofenac, gelrite, HPMC E15LV
 The Efficacy of Favipiravir Therapy in COVID-19 Patients: A Review Article Kurniawansyah, Insan Sunan; Amelia, Nisa Ayu
Indonesian Journal of Pharmaceutics Vol 7, Issue 2, May - August 2025
Publisher : Universitas Padjadjaran (Unpad)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24198/idjp.v7i2.68959

Abstract

The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease 2019 (COVID-19), has resulted in a major global public health crisis. In the absence of a universally approved specific antiviral therapy, several existing antiviral agents have been repurposed, including favipiravir. Favipiravir is a purine nucleoside analog that inhibits RNA-dependent RNA polymerase (RdRp), an essential enzyme for viral RNA replication. This review aims to evaluate the clinical efficacy of favipiravir therapy in patients with COVID-19. A narrative literature review was conducted using databases such as PubMed and Google Scholar, including national and international peer-reviewed journals published between 2019 and 2021. Clinical trials, randomized controlled trials, and observational studies assessing favipiravir in COVID-19 patients were included, while articles lacking accessible full texts or reliable data were excluded. The reviewed studies indicate that favipiravir therapy is associated with improved clinical outcomes, including reduced duration of fever and cough and accelerated viral clearance within 7–14 days of hospitalization, particularly in patients with mild to moderate COVID-19. However, considerable variability in outcomes was observed due to differences in study design, sample size, dosing regimens, comparator therapies, and treatment duration. Overall, favipiravir demonstrates potential as an antiviral therapy for COVID-19; nevertheless, large-scale, well-designed randomized controlled trials are required to definitively confirm its efficacy and safety across different patient populations. 
Co-Authors Amelia, Nisa Ayu Arif Budiman Ghozali, Dolih Insi Farisa Desy Arya Iyan Sopyan Kautsar, Angga P. Yoga Windhu Wardhana Zubaidah, and